Trial Profile
Phase II clinical trial of ReN-003 in the patients with in cone-rod dystrophy
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 22 Dec 2017
Price :
$35
*
At a glance
- Drugs ReN 003 (Primary)
- Indications Cone rod dystrophies
- Focus Therapeutic Use
- 22 Dec 2017 New trial record